Envestnet Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21M Buy
73,072
+1,163
+2% +$334K 0.01% 1228
2025
Q1
$22.2M Buy
71,909
+11,029
+18% +$3.4M 0.01% 1131
2024
Q4
$21.5M Buy
60,880
+2,889
+5% +$1.02M 0.01% 1156
2024
Q3
$20.8M Buy
57,991
+9,010
+18% +$3.23M 0.01% 1161
2024
Q2
$15.6M Buy
48,981
+5,531
+13% +$1.76M 0.01% 1269
2024
Q1
$9.98M Sell
43,450
-2,509
-5% -$576K ﹤0.01% 1526
2023
Q4
$10.1M Buy
45,959
+421
+0.9% +$92.6K ﹤0.01% 1441
2023
Q3
$10.3M Sell
45,538
-7,656
-14% -$1.73M ﹤0.01% 1356
2023
Q2
$11.7M Sell
53,194
-482,990
-90% -$107M 0.01% 1203
2023
Q1
$11.8M Buy
536,184
+477,636
+816% +$10.5M 0.01% 1153
2022
Q4
$16.3M Buy
58,548
+8,327
+17% +$2.32M 0.01% 957
2022
Q3
$10.5M Sell
50,221
-496
-1% -$104K 0.01% 1101
2022
Q2
$12M Sell
50,717
-10,921
-18% -$2.57M 0.01% 1054
2022
Q1
$11.1M Buy
61,638
+2,088
+4% +$375K 0.01% 1148
2021
Q4
$12.9M Buy
59,550
+4,743
+9% +$1.02M 0.01% 1063
2021
Q3
$10.1M Buy
54,807
+39,325
+254% +$7.26M 0.01% 1145
2021
Q2
$2.78M Buy
15,482
+2,180
+16% +$391K ﹤0.01% 1856
2021
Q1
$2.23M Buy
13,302
+2,647
+25% +$443K ﹤0.01% 1870
2020
Q4
$1.62M Sell
10,655
-1,857
-15% -$282K ﹤0.01% 1886
2020
Q3
$1.26M Sell
12,512
-1,690
-12% -$171K ﹤0.01% 1878
2020
Q2
$1.72M Buy
14,202
+11,652
+457% +$1.41M ﹤0.01% 1662
2020
Q1
$242K Sell
2,550
-7,289
-74% -$692K ﹤0.01% 2655
2019
Q4
$867K Buy
9,839
+874
+10% +$77K ﹤0.01% 2120
2019
Q3
$715K Buy
8,965
+1,863
+26% +$149K ﹤0.01% 2166
2019
Q2
$554K Buy
7,102
+230
+3% +$17.9K ﹤0.01% 2337
2019
Q1
$807K Buy
6,872
+4,259
+163% +$500K ﹤0.01% 2023
2018
Q4
$285K Buy
+2,613
New +$285K ﹤0.01% 2456
2018
Q3
Sell
-857
Closed -$96K 2566
2018
Q2
$96K Sell
857
-12
-1% -$1.34K ﹤0.01% 1994
2018
Q1
$97K Sell
869
-140
-14% -$15.6K ﹤0.01% 1924
2017
Q4
$149K Sell
1,009
-7,502
-88% -$1.11M ﹤0.01% 1968
2017
Q3
$997K Buy
8,511
+7,085
+497% +$830K ﹤0.01% 1166
2017
Q2
$182K Sell
1,426
-962
-40% -$123K ﹤0.01% 1907
2017
Q1
$322K Sell
2,388
-3,321
-58% -$448K ﹤0.01% 1733
2016
Q4
$819K Buy
5,709
+836
+17% +$120K ﹤0.01% 1261
2016
Q3
$575K Sell
4,873
-1,998
-29% -$236K ﹤0.01% 1494
2016
Q2
$728K Buy
6,871
+1,592
+30% +$169K ﹤0.01% 1481
2016
Q1
$588K Buy
5,279
+432
+9% +$48.1K ﹤0.01% 1564
2015
Q4
$759K Buy
4,847
+171
+4% +$26.8K ﹤0.01% 1415
2015
Q3
$614K Sell
4,676
-33
-0.7% -$4.33K ﹤0.01% 1505
2015
Q2
$819K Sell
4,709
-434
-8% -$75.5K ﹤0.01% 1491
2015
Q1
$887K Buy
5,143
+4,159
+423% +$717K ﹤0.01% 1340
2014
Q4
$127K Sell
984
-211
-18% -$27.2K ﹤0.01% 1115
2014
Q3
$154K Sell
1,195
-213
-15% -$27.4K ﹤0.01% 1170
2014
Q2
$125K Sell
1,408
-210
-13% -$18.6K ﹤0.01% 1144
2014
Q1
$152K Sell
1,618
-68
-4% -$6.39K ﹤0.01% 1000
2013
Q4
$191K Buy
1,686
+149
+10% +$16.9K ﹤0.01% 837
2013
Q3
$121K Buy
1,537
+542
+54% +$42.7K ﹤0.01% 926
2013
Q2
$65K Buy
+995
New +$65K ﹤0.01% 1114